Evidence map›Paper›PMID 30094784›Full record

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2018

Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Results of a Multinational, Multicenter, Observational Survey (DIAINFORM).

Jan Brož, Denisa Janíčková Žďárská, Jana Urbanová, Marek Brabec, Viera Doničová, Radka Štěpánová, Emil Martinka, Milan Kvapil

Open access · goldAbstract read
In one paragraph

Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. New Frontiers in Diabetes Care.Journal of general internal medicine · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Results of Insulin Therapy in Type 2 Diabetes Mellitus Patients in the Czech Republic: Do They Reflect the Current Status in Other Countries?Diabetes therapy : research, treatment and education of diabetes and related disorders · 2019
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jan BrožDepartment of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Prague, Czech Republic. zorb@seznam.cz.ORCID http://orcid.org/0000-0003-2465-7333
Denisa Janíčková ŽďárskáDepartment of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Prague, Czech Republic.
Jana UrbanováCenter for Research in Diabetes, Metabolism and Nutrition, 2nd Department of Internal Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Marek BrabecInstitute of Computer Science of the ASCR, v.v.i., Prague, Czech Republic.
Viera DoničováPrivate Department of Diabetology Internal Medicine and Metabolism, Kosice, Slovakia.
Radka ŠtěpánováAprova sro, Brno, Czech Republic.
Emil MartinkaNational Institute of Endocrinology and Diabetology, Lubochna, Slovakia.
Milan KvapilDepartment of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Prague, Czech Republic.
Charles University · CZCzech Academy of Sciences, Institute of Computer Science · CZInstitute of Experimental Endocrinology of the Slovak Academy of Sciences · SKUniversity of Veterinary Medicine in Košice · SK

Funding

Sanofi Czech Republic N/A
6 · The paper itself

Abstract

introductionThe aim of the study was to determine the level of metabolic control in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) patients in the Czech and Slovak Republics.

methodsA non-interventional prospective (observational) study was conducted from January 2015 until April 2016 in routine clinical practice settings at 141 centers in the Czech and Slovak Republics. Data were analyzed from a total of 425 patients with T1DM and 1034 patients with T2DM, proportionally corresponding to the number of patients in both countries. The primary objective of the study was to determine the percentage of patients with HbA1c < 7% (53 mmol/mol).

resultsPatients with T1DM: In this group of patients (55.8% males, mean age 45.9 ± 14.83 years, BMI 25.8 ± 4.21 kg/m², diabetes duration 12.1 ± 9.44 years), 29.9% reached HbA1c levels < 53 mmol/mol. Patients with T2DM: In this group of patients (50.3% male, mean age 63.9 ± 9.65 years, BMI 31.0 ± 5.19 kg/m², diabetes duration 12.4 ± 7.47 years, duration of insulin therapy 5.8 ± 4.71 years), 33.4% reached HbA1c levels < 53 mmol/mol.

conclusionThe overall percentage of patients with HbA1c < 53 mmol/mol in the T1DM group was 29.9% and in the T2DM group was 33.4%. Despite an increasing number of treatment options, most patients still fail to reach the recommended HbA1c targets.

fundingSanofi, Czech Republic.

Indexed as

Clinical inertiaHbA1cInsulin therapyMetabolic controlType 1 diabetesType 2 diabetes

Identifiers

PMID30094784
PMCPMC6167301
OpenAlexW2887705980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.